OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e711-e720
Open Access | Times Cited: 175
Jay Park, Robin Mogg, Gerald E. Smith, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e711-e720
Open Access | Times Cited: 175
Showing 1-25 of 175 citing articles:
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
Harnessing the power of clinical decision support systems: challenges and opportunities
Chen Zhao, Ning Liang, Haili Zhang, et al.
Open Heart (2023) Vol. 10, Iss. 2, pp. e002432-e002432
Open Access | Times Cited: 51
Chen Zhao, Ning Liang, Haili Zhang, et al.
Open Heart (2023) Vol. 10, Iss. 2, pp. e002432-e002432
Open Access | Times Cited: 51
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Perfil clínico e fatores associados ao óbito de pacientes COVID-19 nos primeiros meses da pandemia
Letícia Pontes, Mitzy Tânnia Reichembach Danski, Simone Martins Nascimento Piubello, et al.
Escola Anna Nery (2021) Vol. 26
Open Access | Times Cited: 62
Letícia Pontes, Mitzy Tânnia Reichembach Danski, Simone Martins Nascimento Piubello, et al.
Escola Anna Nery (2021) Vol. 26
Open Access | Times Cited: 62
Data capture and sharing in the COVID-19 pandemic: a cause for concern
Louis Dron, Vinusha Kalatharan, Alind Gupta, et al.
The Lancet Digital Health (2022) Vol. 4, Iss. 10, pp. e748-e756
Open Access | Times Cited: 51
Louis Dron, Vinusha Kalatharan, Alind Gupta, et al.
The Lancet Digital Health (2022) Vol. 4, Iss. 10, pp. e748-e756
Open Access | Times Cited: 51
Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a pragmatic, cluster-randomised trial in seven low-income and middle-income countries
Aaron B Andoh, Abantanga Atindaana Francis, Abdulhafiz A Abdulkarim, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1767-1776
Open Access | Times Cited: 47
Aaron B Andoh, Abantanga Atindaana Francis, Abdulhafiz A Abdulkarim, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1767-1776
Open Access | Times Cited: 47
COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis
Tahani Al Rahbeni, Prakasini Satapathy, Ramaiah Itumalla, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e54769-e54769
Open Access | Times Cited: 11
Tahani Al Rahbeni, Prakasini Satapathy, Ramaiah Itumalla, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e54769-e54769
Open Access | Times Cited: 11
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 7
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 7
Challenges and solutions in clinical research during the COVID‐19 pandemic: A narrative review
Mahin Nomali, Neda Mehrdad, Mohammad Heidari, et al.
Health Science Reports (2023) Vol. 6, Iss. 8
Open Access | Times Cited: 18
Mahin Nomali, Neda Mehrdad, Mohammad Heidari, et al.
Health Science Reports (2023) Vol. 6, Iss. 8
Open Access | Times Cited: 18
The impact of COVID-19 on global health journals: an analysis of impact factor and publication trends
Jiaxin He, Xinliang Liu, Xinyang Lu, et al.
BMJ Global Health (2023) Vol. 8, Iss. 4, pp. e011514-e011514
Open Access | Times Cited: 17
Jiaxin He, Xinliang Liu, Xinyang Lu, et al.
BMJ Global Health (2023) Vol. 8, Iss. 4, pp. e011514-e011514
Open Access | Times Cited: 17
Artificial intelligence for dementia genetics and omics
Conceição Bettencourt, Nathan Skene, Sara Bandrés‐Ciga, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5905-5921
Open Access | Times Cited: 16
Conceição Bettencourt, Nathan Skene, Sara Bandrés‐Ciga, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5905-5921
Open Access | Times Cited: 16
Leveraging the HIV response to strengthen pandemic preparedness
Chris Collins, Michael Isbell, Quarraisha Abdool Karim, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 1, pp. e0001511-e0001511
Open Access | Times Cited: 15
Chris Collins, Michael Isbell, Quarraisha Abdool Karim, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 1, pp. e0001511-e0001511
Open Access | Times Cited: 15
Clinical trials and their impact on policy during COVID-19: a review
Paul Glasziou, Sharon Sanders, Oyungerel Byambasuren, et al.
Wellcome Open Research (2024) Vol. 9, pp. 20-20
Open Access | Times Cited: 6
Paul Glasziou, Sharon Sanders, Oyungerel Byambasuren, et al.
Wellcome Open Research (2024) Vol. 9, pp. 20-20
Open Access | Times Cited: 6
Global landscape of COVID-19 research: a visualization analysis of randomized clinical trials
Sa’ed H. Zyoud
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Sa’ed H. Zyoud
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Identification of climate-sensitive disease incidences in Vietnam: a longitudinal retrospective analysis of infectious disease rates between 2014 and 2022
Cuong Hoang, Quang T. Nguyen, T. Nguyen, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41902-e41902
Open Access
Cuong Hoang, Quang T. Nguyen, T. Nguyen, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41902-e41902
Open Access
The importance of rigor in pharmacy research: challenges and solutions
Michael R. Gionfriddo, Chyna McClendon, David Nolfi, et al.
Research in Social and Administrative Pharmacy (2025)
Closed Access
Michael R. Gionfriddo, Chyna McClendon, David Nolfi, et al.
Research in Social and Administrative Pharmacy (2025)
Closed Access
Fostering public trust in national health data platforms: key considerations for public involvement activities for England and Switzerland
Paola Daniore, Katherine-Helen Hurndall, F Zavattaro, et al.
Data & Policy (2025) Vol. 7
Open Access
Paola Daniore, Katherine-Helen Hurndall, F Zavattaro, et al.
Data & Policy (2025) Vol. 7
Open Access
Mixed-methods study to develop extensions to the SPIRIT and CONSORT statements for factorial randomised trials: the Reporting Factorial Trials (RAFT) study
Sophie Hall, Edmund Juszczak, Megan Birchenall, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e082917-e082917
Open Access
Sophie Hall, Edmund Juszczak, Megan Birchenall, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e082917-e082917
Open Access
Hospital Preparedness for Conducting Clinical Research During a Pandemic: A Nationwide Survey Among Designated Medical Institutions for Infectious Diseases in Japan
Kazuaki Jindai, Hiroki Saito, Eriko Morino, et al.
Health Security (2025)
Closed Access
Kazuaki Jindai, Hiroki Saito, Eriko Morino, et al.
Health Security (2025)
Closed Access
IRIS: A Prototype for GDPR Health Research Compliance
L. Ferreira, Teresa Martins, E Dias, et al.
Communications in computer and information science (2025), pp. 131-149
Closed Access
L. Ferreira, Teresa Martins, E Dias, et al.
Communications in computer and information science (2025), pp. 131-149
Closed Access
Burden and care time for dementia caregivers in the LIVE@Home.Path trial
Line Iden Berge, Renira C. Angeles, Marie H. Gedde, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Line Iden Berge, Renira C. Angeles, Marie H. Gedde, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Urgently seeking efficiency and sustainability of clinical trials in global health
Jay Park, Rebecca F. Grais, Monica Taljaard, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e681-e690
Open Access | Times Cited: 32
Jay Park, Rebecca F. Grais, Monica Taljaard, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e681-e690
Open Access | Times Cited: 32
Insights Into JKMS Submissions and Medical Journal Publications in Korea
Jaehun Jung, Yumi Jang, Munkhzul Radnaabaatar, et al.
Journal of Korean Medical Science (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
Jaehun Jung, Yumi Jang, Munkhzul Radnaabaatar, et al.
Journal of Korean Medical Science (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
Sustained Rise in Retractions in the Life Sciences Literature during the Pandemic Years 2020 and 2021
Nicole Shu Ling Yeo-Teh, Bor Luen Tang
Publications (2022) Vol. 10, Iss. 3, pp. 29-29
Open Access | Times Cited: 20
Nicole Shu Ling Yeo-Teh, Bor Luen Tang
Publications (2022) Vol. 10, Iss. 3, pp. 29-29
Open Access | Times Cited: 20
